加拿大的SARS-CoV-2血统和疫苗状态的儿童COVID-19严重程度:一个IMPACT研究
Daniel S Farrar1, Julie A Bettinger2,3, Aaron J Campigotto4
1Centre for Global Child Health, The Hospital for Sick Children, Toronto, ON, Canada.
Pediatric research
|January 24, 2025
概括
儿童的COVID-19住院治疗增加了Omicron血统,但疫苗接种降低了老年儿童的严重疾病风险. 疫苗还降低了5至16岁儿童的整体住院率.
科学领域:
- 儿童传染病 儿童传染病
- 流行病学 流行病学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 儿科COVID-19的严重程度受到SARS-CoV-2变异的演变和疫苗可用性的影响.
- 了解这些因素对于公共卫生战略至关重要.
- 加拿大监控数据为这些趋势提供了洞察力.
研究的目的:
- 根据SARS-CoV-2血统,估计住院加拿大儿童患重症COVID-19的风险.
- 评估COVID-19疫苗接种状态对疾病严重程度的影响.
- 分析不同Omicron子系的趋势.
主要方法:
- 利用了加拿大儿科监测计划和加拿大免疫监测计划ACTive的数据.
- 包括从2020年4月至2022年12月因COVID-19住院的17岁以下儿童.
- 通过遗传测序或主导血统分析定义了严重疾病并确定了SARS-CoV-2血统.
主要成果:
- 奥米克朗血统占住院病例的81.4%;患有奥米克朗的儿童住院病例比所有先前的血统病例加起来还要多.
- 在Omicron (27.2%) 和Delta (23.2%) 期间,严重的COVID-19是常见的.
- 疫苗接种减少了12-16岁儿童的严重疾病风险 (aRR为0.49) 和5-16岁儿童的住院治疗.
结论:
- 与之前的菌株相比,Omicron系导致儿童COVID-19住院的负担更高.
- 接种COVID-19疫苗显示有保护作用,在特定的儿科年龄组中减少了严重疾病和住院治疗.
更多相关视频
06:08Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research
Published on: September 8, 2023
1.1K
05:31Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
10.3K
相关概念视频
Viral Mutations
32.1K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.1K
Vaccinations
43.9K
Overview
43.9K
